Page last updated: 2024-08-23

pyrrolidine and Hyperparathyroidism

pyrrolidine has been researched along with Hyperparathyroidism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, H; Hisada, Y; Idei, A; Iguchi, T; Ikeda, Y; Kannami, A; Kawata, T; Kifuji, T; Kojima, K; Kuroda, M; Miyake, T; Miyazaki, H; Moritani, Y; Ohashi, R; Okabe, J; Sakairi, T; Sakurai, O; Sato, N; Tokunaga, S; Tsubota, R; Tsukumo, Y; Yanagida, T; Yoneda, H	1

Other Studies

1 other study(ies) available for pyrrolidine and Hyperparathyroidism

Article	Year
Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism. Bioorganic & medicinal chemistry letters, 2018, 06-15, Volume: 28, Issue:11 Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hyperparathyroidism; Models, Molecular; Molecular Structure; Pyrrolidines; Rats; Receptors, Calcium-Sensing; Structure-Activity Relationship	2018

Article

Year

Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism.

Bioorganic & medicinal chemistry letters, 2018, 06-15, Volume: 28, Issue:11

Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hyperparathyroidism; Models, Molecular; Molecular Structure; Pyrrolidines; Rats; Receptors, Calcium-Sensing; Structure-Activity Relationship

2018